Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F1BD
|
||||
| Former ID |
DNC009972
|
||||
| Drug Name |
1-Biphenyl-4-ylmaleimide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530251] | ||
| Formula |
C16H11NO2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)N3C(=O)C=CC3=O
|
||||
| InChI |
1S/C16H11NO2/c18-15-10-11-16(19)17(15)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-11H
|
||||
| InChIKey |
RXWKCYQPTDVVSI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530251] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.